Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Immunizations in Immunocomprised Patients

  |  Issue: August 2009  |  

In her closing remarks, Dr. Kotton also touched on issues of infectious disease prevention in children with juvenile idiopathic arthritis and urged her colleagues to make use of the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System to help add to the knowledge base about zoster vaccines in immunosuppressed patients.5

References

  1. Gluck T, Muller-Ladner U. Vaccination in patients with chronic rheumatic or autoimmune disease. Clin Infect Dis. 2008;46:1459-1465.
  2. Saag KG, Teng GG, Patkar NM, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum. 2008;59:762-784.
  3. Oxman MN, Levin MJ. Shingles Prevention Study Group. Vaccination against herpes zoster and postherpetic neuralgia. J Infect Dis. 2008;197 Suppl 2:S228-S238.
  4. Harpaz R, Ortega-Sanchez IR, Seward JF. Advisory Committee on Immunization Practices; Centers for Disease Control and Prevention. Prevention of herpes zoster: Recommendations from the Advisory Committee on Immunization Practices. MMWR Recomm Rep. June 6, 2008;57:1-30.
  5. Centers for Disease Control and Prevention; Food and Drug Administration. Vaccine Adverse Event Reporting System. Available at: http://vaers.hhs.gov/vaers.htm. Accessed May 17, 2009.

Related Articles

    Vax Hesitancy? Myths & Facts for Patients

    Although more than 189,300,000 eligible Americans are fully vaccinated against SARS-CoV-2 as of Oct. 18, 2021, vaccine hesitancy persists.1 The U.S. Centers for Disease Control and Prevention (CDC), citing data from the U.S. Census Bureau’s Household Pulse Survey collected between May 26 and June 7, 2021, reports that in some U.S. counties—particularly in the Southeast…

    A Shot of Wisdom: Vaccinations in Patients with Rheumatic Disease

    PHILADELPHIA—The treatment of rheumatic diseases is often a double-edged sword: immunosuppressive regimens can be very effective in reducing disease activity, but the cost of such treatments may be seen in the form of increased risk of infection. At ACR Convergence 2022, the session titled ACR Guidelines for Vaccination in Patients with Rheumatic and Musculoskeletal Diseases…

    Anze Furlan / SHUTTERSTOCK.COM

    How Immunosuppression May Affect COVID-19 Vaccine Response

    Although we can expect to learn much more, preliminary data are now available on the potential safety and effectiveness of COVID-19 vaccines in rheumatology patients. The picture is likely to be nuanced, with not all types of immuno­suppressive treatments having identical impacts on vaccine response. Rheumatologists should use caution in interpreting early reports, while continuing…